payor coverage Biocept HER2 Assay Gains Coverage Under Medicare Local Coverage Determination for CTC Tests Under the LCD, CTC assays, such as Biocept's, will now be covered to guide targeted treatment decisions for patients with breast and other cancers under certain circumstances. Concert Genetics New Test ID Tool Works to Improve Reimbursement Process Premium The company previously launched its Concert Coding Engine to help standardize how genetic tests are coded and how labs can bill for them. New AMP Survey Reports Insufficient Reimbursement for Analysis, Interpretation of MDx Test Results The survey found analysis, interpretation, and reporting requirements can take more than six hours per test but that reimbursement for tests doesn't account for this work. Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test Bio-Techne's CEO said the coverage decision will expand access to its EPI test and enable additional men to better decide whether to proceed with a prostate biopsy. German Medical Center to Report Polygenic Risk Scores as Part of Clinical Whole-Genome Testing Premium Under the Ge-Med project, University Hospital Tübingen will offer diagnostic whole-genome sequencing for all genetic indications and will include PRS in its reporting. Jan 26, 2021 Genomind Receives Medicare Coverage for Pharmacogenetics Test Jan 20, 2021 CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon Dec 8, 2020 Illumina, Harvard Pilgrim Health Care Ink Risk-Sharing Deal for Whole-Genome Sequencing Dec 3, 2020 Aetna Updates Noninvasive Prenatal Testing Coverage Policy to Include All Pregnancies Dec 1, 2020 UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies Nov 20, 2020 Increased Adoption of Whole-Genome Sequencing Testing Hinges on Acceptance by Payors, Providers Premium Nov 19, 2020 Progenity to Cut Workforce as Third-Party Payor Seeks $27.4M for Alleged Overpayment Oct 29, 2020 Humana Broadens Coverage of NIPT for Average Risk Pregnancies Oct 19, 2020 CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon Oct 15, 2020 Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests Oct 8, 2020 Centene Expands Coverage of Natera NIPT to All Pregnant Women Sep 21, 2020 Biocept Lung Cancer Liquid Biopsy Test Obtains Coverage From Blue Cross Affiliate Highmark Aug 6, 2020 NantHealth Q2 Revenues Decline 12 Percent Jul 8, 2020 Payor Policy Study Reveals Progress, Challenges in Liquid Biopsy Reimbursement Jun 18, 2020 State-Funded Rapid WGS Pilot Improves Outcomes, Saves Costs in Critically Ill California Newborns Premium May 20, 2020 Bio-Techne Bets Clinical Utility Study Data Will Sway Payors to Cover Prostate Cancer Risk Test Premium May 12, 2020 Natera Cell-Free DNA Organ Transplant Test Receives Positive Coverage From Noridian Apr 12, 2020 CMS Issues Guidance on Payor Coverage of Coronavirus Testing Mar 16, 2020 House Passes Bill to Cover Coronavirus Testing with Emergency Use Authorization Mar 9, 2020 Blue Shield of California to Cover Rady Children's Rapid Whole-Genome Sequencing Test Load More Breaking News Myasthenia Gravis Study Identifies Genetic Risk Loci Affecting Acetylcholine Receptor Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA Illumina, National Cancer Center Japan Collaborate on Nasopharyngeal Cancer Study Fluidigm Obtains $250M Investment, Changing Name to Standard BioTools SeqOne Genomics Closes €20M Series A Financing NeoGenomics Partners With Biomarker Collaborative to Provide Lung Cancer Resources The Scan For STEM Students to Stay New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports. To Inform or Not, To Know or Not The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information. Rapid Test Studies Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says. PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.